Association Between Serum Vitamin D, Inflammatory Biomarkers, and Clinical Severity in Dogs with Chronic Dermatological Diseases

Main Article Content

Hamidreza Shojaei
Mohammad Reza Deylami
Pouya Mirali
Mohammad Sadegh Khanbabaii
Maedeh Taghinezhad
Mohammad Talebi Daloei
Mohammad Reza Mollaei
Erfan Karimi

Abstract

Introduction: Chronic dermatological diseases are common in dogs and are often linked to persistent inflammation, immune dysregulation, and reduced quality of life. Vitamin D has important immunomodulatory and anti-inflammatory properties. This study aimed to investigate the association between serum vitamin D levels, inflammatory biomarkers, and clinical severity in dogs with chronic dermatological diseases.
Materials and methods: This case-control study included 30 dogs with chronic dermatological diseases and 30 clinically healthy dogs as controls, conducted between March 2025 and May 2026. The mean age of dogs was 4 years (1.8-7.5 years), and the mean body weight was 19.1 kg (8.5-30.5 kg). Of the 15 male dogs, 10 were neutered, and of the 15 female dogs, 12 were spayed. The clinical severity of dermatological diseases was assessed by the Canine atopic dermatitis extent and severity index, 4th iteration, and the Pruritus visual analog scale. Blood samples were collected on day 1 from all dogs for serum Vitamin D, C-reactive protein (CRP), and interleukin-6 (IL-6) measurements. Complete blood counts were obtained, and the neutrophil-to-lymphocyte ratio (NLR) was calculated on day 1. At the end of the study period, dogs affected by dermatological diseases and healthy dogs were compared for serum vitamin D levels and inflammatory biomarkers.
Results: Dogs with chronic dermatological diseases had significantly lower serum vitamin D levels and higher CRP (12.4 mg/L), IL-6 (42.6 pg/mL), and NLR (4.8) than controls. Lower vitamin D status in dogs with chronic dermatological diseases correlated with higher clinical disease severity and higher pruritus scores. Vitamin D concentrations negatively correlated with CRP, IL-6, and NLR, whereas CRP and IL-6 positively correlated with clinical severity in dogs with chronic dermatological diseases. The current results indicated that lower serum vitamin D levels were significantly associated with more severe dermatological manifestations after adjusting for age, body weight, sex, and neuter status.
Conclusion: The current results demonstrated that decreased serum vitamin D levels were associated with increased systemic inflammation and increased clinical severity in dogs with chronic dermatologic diseases. Thus, serum vitamin D levels and inflammatory biomarkers can serve as an adjunctive indicator of disease severity in dogs.

Article Details

How to Cite
Shojaei, H., Deylami, M. R., Mirali, P., Khanbabaii, M. S., Taghinezhad, M., Talebi Daloei, M., Mollaei, M. R., & Karimi, E. (2026). Association Between Serum Vitamin D, Inflammatory Biomarkers, and Clinical Severity in Dogs with Chronic Dermatological Diseases. Small Animal Advances, 5(3), 42–47. Retrieved from https://saa.rovedar.com/index.php/SAA/article/view/61
Section
Original Articles

References

Drechsler Y, Dong C, Clark DE, and Kaur G. Canine atopic dermatitis: prevalence, impact, and management strategies. Vet Med Res Rep. 2024; 15: 15-29. DOI: 10.2147/VMRR.S412570

Malinovská Z, and Fekeová L. Dermatological Diseases in Dogs‒A Survey in Veterinary Facilities. Folia Vet. 2023; 67(4): 34-40. DOI: 10.2478/fv-2023-0035

Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov. 2023; 22(8): 662-680. DOI: 10.1038/s41573-023-00735-0

Sassi F, Tamone C, and D’Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018; 10(11): 1656. DOI: 10.3390/nu10111656

Sharp CR, Selting KA, and Ringold R. The effect of diet on serum 25-hydroxyvitamin D concentrations in dogs. BMC Res Notes. 2015; 8: 442. DOI: 10.1186/s13104-015-1360-0

Herrmann M, Farrell CJ, Pusceddu I, Fabregat-Cabello N, and Cavalier E. Assessment of vitamin D status - a changing landscape. Clin Chem Lab Med. 2017; 55(1): 3-26. DOI: 10.1515/cclm-2016-0264

Bukvić Mokos Z, Tomić Krsnik L, Harak K, Marojević Tomić D, Tešanović Perković D, and Vukojević M. Vitamin D in the prevention and treatment of inflammatory skin diseases. Int J Mol Sci. 2025; 26(11): 5005. DOI: 10.3390/ijms26115005

Klinger CJ, Hobi S, Johansen C, Koch HJ, Weber K, and Mueller RS. Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis. Vet Rec. 2018; 182(14): 406. DOI: 10.1136/vr.104492

Chrobak-Chmiel D, Golke A, Kwiecień E, Biegańska MJ, Dembele K, Dziekiewicz-Mrugasiewicz M, et al. Is vitamin D3 a worthy supplement protecting against secondary infections in dogs with atopic dermatitis? Pathogens. 2023; 12(1): 145. DOI: 10.3390/pathogens12010145

Casini L, Zago D, Cavicchioli E, and Tomiazzo C. Serum 25-hydroxyvitamin D concentration in Japanese Akita dogs: A survey. Vet Anim Sci. 2020; 10: 100139. DOI: 10.1016/j.vas.2020.100139

Fransson BA, Lagerstedt AS, Bergstrom A, Hagman R, Park JS, Chew BP, Evans MA, and Ragle CA. C‐reactive protein, tumor necrosis factor α, and interleukin‐6 in dogs with pyometra and SIRS. J Vet Emerg Crit Care. 2007; 17(4): 373-381. DOI: 10.1111/j.1476-4431.2006.00203.x

Sproston NR, and Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 13 (9): 754. DOI: 10.3389/fimmu.2018.00754

Yameny AA. IL-6, TNF-α, IL-1β, and IFN-γ cytokines as core inflammatory biomarkers: biological roles, diagnostic utility, and clinical applications. J Biosci Appl Res. 2025; 11(3): 1055-1061. Available at: https://journals.ekb.eg/article_456942.html

Herrmann I, Mamo LB, and Bizikova P. Systemic inflammation in dogs with atopic dermatitis compared to healthy dogs and dogs with pemphigus foliaceus: A study using a limited cytokine panel. Vet Dermatol. 2026; 1-7. DOI: 10.1111/vde.70118

Buonacera A, Stancanelli B, Colaci M, and Malatino L. Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022; 23(7): 3636. DOI: 10.3390/ijms23073636

Favrot C, Steffan J, Seewald W, and Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol. 2010; 21(1): 23-31. DOI: 10.1111/j.1365-3164.2009.00758.x

Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, and Hill PB. International Committee on allergic diseases of animals (ICADA). Validation of the canine atopic dermatitis extent and severity index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Vet Dermatol. 2014; 25(2): 77-e25. DOI: 10.1111/vde.12107

Hill PB, Lau P, and Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol. 2007;18: 301-308. DOI: 10.1111/j.1365-3164.2007.00616.x

Ersfeld DL, Rao DS, Body JJ, Sackrison Jr JL, Miller AB, Parikh N, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer. Clin Biochem. 2004; 1; 37(10): 867-874. DOI: 10.1016/j.clinbiochem.2004.06.006

Hillström A, Hagman R, Söder J, Häggström J, Ljungvall I, and Kjelgaard-Hansen M. Validation and application of a canine-specific automated high-sensitivity C-reactive protein assay. J Vet Diagn Invest. 2015; 27(2): 182-190. DOI: 10.1177/1040638715575751

Navarro PF, Monroig M, and Gil-Vicente L. Reference intervals for hematological inflammatory ratios in healthy dogs. Animals. 2025; 15(23): 3376. DOI: 10.3390/ani15233376

Jaffey JA, Kreisler R, Backus RC, Gordon D, and Chittick L. Effects of short-term calcifediol supplementation on leukocyte cytokine production in healthy dogs: a randomized, double-blinded, placebo-controlled crossover trial. J Vet Intern Med. 2025; 39(5): e70240. DOI: 10.1111/jvim.70240

Jaffey JA, Backus RC, Kreisler R, Graves TK, Al-Nakkash L, and Allison L. Evaluation of serum vitamin D metabolites, phagocytosis, and biomarkers of inflammation in dogs with naturally occurring diabetes mellitus. Front Vet Sci. 2024; 11: 1441993. DOI: 10.3389/fvets.2024.1441993

Daniluk U, Filimoniuk A, Kowalczuk-Krystoń M, Alifier M, Karpińska J, Kaczmarski MG, and Lebensztejn DM. Association of antioxidants and vitamin D level with inflammation in children with atopic dermatitis. Int J Dermatol. 2019; 58(9): 1056-1061. DOI: 10.1111/ijd.14451

Bergeron C, Costa MC, Segura M, de Souza LB, Bleuzé M, and Sauvé F. Bacterial microbiota and proinflammatory cytokines in the anal sacs of treated and untreated atopic dogs: comparison with a healthy control group. PLoS One. 2024; 19(5): e0298361. DOI: 10.1371/journal.pone.0298361

Park S, Kim S, Hong YJ, Park JH, Han M, Lee Y, et al. Blood neutrophil-to-lymphocyte ratio as a potential prognostic marker in dogs ≤10 kg with multicentric lymphoma. Vet Comp Oncol. 2024; 22(4): 470-479. DOI: 10.1111/vco.12993

Hurst EA, Homer NZ, Gow AG, Clements DN, Evans H, Gaylor D, et al. Vitamin D status is seasonally stable in northern European dogs. Vet Clin Pathol. 2020; 49(2): 279-291. DOI: 10.1111/vcp.12859